Table 1 Patient clinical characteristic

Age (years)

59 ± 7

59 ± 11

58 ± 11

[41, 68]

[37, 77]

[36, 74]

Gender

Male

7

20

15

Female

4

14

13

Weight (kg)

68.4 ± 13.5

72.0 ± 12.9

72.4 ± 10.3

[45, 98]

[45, 110]

[60, 110]

Height (cm)

164 ± 6

165 ± 7

163 ± 7

[156, 175]

[150, 176]

[150, 178]

BMI (kg/m²)

25.5 ± 4.8

26.5 ± 4.1

27.1 ± 3.4

[15.6, 34.7]

[15.6, 40.4]

[24.0, 40.4]

Blood glucose (mmol/L)

6.2 ± 1.1

5.7 ± 1.1

5.4 ± 0.9

[4.8, 8.8]

[3.9, 8.8]

[3.9, 7.2]

Injected activity (MBq)

259.4 ± 54.2

270.1 ± 48.3

268.7 ± 34.8

[162.8, 376.3]

[162.8, 405.9]

[223.8, 405.9]

Injected activity/weight (MBq/kg)

3.8 ± 0.2

3.8 ± 0.2

3.7 ± 0.2

[3.5, 4.0]

[3.5, 4.6]

[3.4, 4.6]

Uptake time (min)

72 ± 12

72 ± 15

72 ± 17

[53, 101]

[50, 107]

[50, 114]

Primary cancer type^*

Bone cancer

0/1

0/1

1/1

Breast cancer

2/3

2/3

2/3

Colorectal cancer

1/6

5/6

2/6

Esophagus cancer

0/3

0/3

3/3

Gallbladder carcinoma

0/1

1/1

0/1

Liver cancer

0/2

1/2

1/2

Lung cancer

4/10

9/10

8/10

Lung granulomatous inflammation

0/1

1/1

0/1

Lymphoma

2/12

8/12

6/12

Malignant melanoma

0/1

1/1

1/1

Nasopharynx cancer

0/3

2/3

2/3

Neck cancer

1/1

0/1

0/1

Endometrial

0/1

1/1

1/1

Thyroid cancer

1/1

1/1

0/1

Urothelial carcinoma

0/1

1/1

0/1

Uterine cancer

0/1

1/1

1/1

Total

11/48

34/48

28/48